Hologic Inc (HOLX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hologic Inc (HOLX) has a cash flow conversion efficiency ratio of 0.044x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($229.90 Million) by net assets ($5.25 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Hologic Inc (HOLX) net asset quality to measure how much of total assets are equity-financed.
Hologic Inc - Cash Flow Conversion Efficiency Trend (1991–2025)
This chart illustrates how Hologic Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Hologic Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Hologic Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hologic Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bank of Hangzhou Co Ltd
SHG:600926
|
-0.217x |
|
ASICS CORP.(UNSP.ADR)/1
F:ASI
|
N/A |
|
POSCO Holdings Inc
F:PKX
|
0.031x |
|
China Shipbuilding Industry Co Ltd
SHG:601989
|
-0.021x |
|
Weyerhaeuser Company
NYSE:WY
|
0.006x |
|
POSCO Holdings
KO:005490
|
0.004x |
|
CAPGEMINI UNS.ADR 1/5/EO8
F:CGMA
|
N/A |
|
China Satellite Communications Co Ltd
SHG:601698
|
0.017x |
Annual Cash Flow Conversion Efficiency for Hologic Inc (1991–2025)
The table below shows the annual cash flow conversion efficiency of Hologic Inc from 1991 to 2025. For the full company profile with market capitalisation and key ratios, see Hologic Inc market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $5.05 Billion | $1.06 Billion | 0.209x | -16.41% |
| 2024-09-30 | $5.13 Billion | $1.29 Billion | 0.251x | +19.56% |
| 2023-09-30 | $5.02 Billion | $1.05 Billion | 0.210x | -51.93% |
| 2022-09-30 | $4.88 Billion | $2.13 Billion | 0.436x | -21.09% |
| 2021-09-30 | $4.22 Billion | $2.33 Billion | 0.552x | +66.80% |
| 2020-09-30 | $2.71 Billion | $896.60 Million | 0.331x | +16.21% |
| 2019-09-30 | $2.28 Billion | $649.50 Million | 0.285x | -5.56% |
| 2018-09-30 | $2.43 Billion | $732.90 Million | 0.302x | +10024.03% |
| 2017-09-30 | $2.78 Billion | $8.30 Million | 0.003x | -99.19% |
| 2016-09-30 | $2.14 Billion | $787.20 Million | 0.367x | -2.83% |
| 2015-09-30 | $2.08 Billion | $786.10 Million | 0.378x | +53.42% |
| 2014-09-30 | $2.06 Billion | $508.40 Million | 0.246x | -3.11% |
| 2013-09-30 | $1.94 Billion | $493.82 Million | 0.254x | +103.43% |
| 2012-09-30 | $2.96 Billion | $370.22 Million | 0.125x | -19.48% |
| 2011-09-30 | $2.94 Billion | $456.02 Million | 0.155x | -8.25% |
| 2010-09-30 | $2.70 Billion | $456.71 Million | 0.169x | -22.17% |
| 2009-09-30 | $2.51 Billion | $546.37 Million | 0.217x | +176.86% |
| 2008-09-30 | $4.64 Billion | $364.60 Million | 0.079x | -58.71% |
| 2007-09-30 | $805.72 Million | $153.25 Million | 0.190x | +270.18% |
| 2006-09-30 | $605.75 Million | $31.12 Million | 0.051x | -74.78% |
| 2005-09-30 | $217.83 Million | $44.37 Million | 0.204x | +30.86% |
| 2004-09-30 | $166.28 Million | $25.88 Million | 0.156x | +389.99% |
| 2003-09-30 | $148.93 Million | $4.73 Million | 0.032x | -35.01% |
| 2002-09-30 | $142.41 Million | $6.96 Million | 0.049x | +153.31% |
| 2001-09-30 | $111.81 Million | $-10.25 Million | -0.092x | -1681.85% |
| 2000-09-30 | $131.57 Million | $-677.00K | -0.005x | -133.65% |
| 1999-09-30 | $150.40 Million | $2.30 Million | 0.015x | -85.29% |
| 1998-09-30 | $140.40 Million | $14.60 Million | 0.104x | +4.65% |
| 1997-09-30 | $126.80 Million | $12.60 Million | 0.099x | +869.30% |
| 1996-09-30 | $107.30 Million | $1.10 Million | 0.010x | -84.49% |
| 1995-09-30 | $22.70 Million | $1.50 Million | 0.066x | +143.83% |
| 1994-09-30 | $19.90 Million | $-3.00 Million | -0.151x | -719.10% |
| 1993-09-30 | $16.30 Million | $-300.00K | -0.018x | +16.72% |
| 1992-09-30 | $18.10 Million | $-400.00K | -0.022x | +69.24% |
| 1991-09-30 | $16.70 Million | $-1.20 Million | -0.072x | -- |
About Hologic Inc
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms… Read more